KLF4 induces the development of sorafenib resistance within HCC, and the inhibition of KLF4 expression with short hairpin RNA recovered the response of sorafenib-resisted HCC cell lines to sorafenib (223). Here, KLF4 is linked to hepatocellular carcinoma.